CAS Number: 571190-30-2

Stage: Pipeline

Palbociclib is a selective CDK4/6 inhibitor used in combination with endocrine therapy for HR+/HER2- advanced breast cancer. It works by halting the cell cycle, slowing tumor proliferation. Palbociclib is well-established as a standard of care in hormone receptor-positive breast cancer, offering significant progression-free survival benefits. Explore Royal Pharma as your potential partner for Palbociclib API.